The Dipyridamole Added to Dual Antiplatelet Therapy in Cerebral Infarction After First Acute Myocardial Infarction: A Nationwide, Case-Control Study

Background and Purpose: No previous study has compared the impact of dipyridamole-based triple antiplatelet therapy on secondary stroke prevention and long-term outcomes to that of dual antiplatelet therapy (DAPT) in patients with acute myocardial infarction (AMI) and previous stroke. This study aim...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Mei-Tzu Wang, Cheng Ken Tsai, Shu-Hung Kuo, Wei-Chun Huang, Kun-Chang Lin, Wang-Ting Hung, Chin-Chang Cheng, Pei-Ling Tang, Cheng Chung Hung, Jin-Shiou Yang, Hsin-Li Liang, Guang-Yuan Mar, Chun-Peng Liu
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Frontiers Media S.A. 2018-11-01
Serie:	Frontiers in Neurology
Soggetti:	acute myocardial infarction antiplatelet agent dipyridamole stroke dual antiplatelet therapy
Accesso online:	https://www.frontiersin.org/article/10.3389/fneur.2018.01003/full
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!